Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.45 |
| ▸ | PTAFR | P25105 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | LIPE | Q05469 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL641829 | 0.91 | CYP1A2 (0.43) | CYP1A2TDP1SMN1; SMN2KDM4ENOTUM | |
| SCHEMBL7379323 | 0.85 | — | — | |
| SCHEMBL11070126 | 0.84 | CYP1A2 (0.50) | CYP1A2TDP1SMN1; SMN2KDM4ENOTUM | |
| SCHEMBL14720829 | 0.79 | CYP1A2 (0.50) | CYP1A2TDP1SMN1; SMN2KDM4ENOTUM | |
| SCHEMBL15334705 | 0.79 | LIPE (0.36) | NOTUMLIPEALDH1A1KMT2A | |
| SCHEMBL2161595 | 0.79 | CYP1A2 (0.50) | CYP1A2TDP1SMN1; SMN2KDM4ENOTUM | |
| SCHEMBL24120035 | 0.78 | LIPE (0.38) | NOTUMLIPEALDH1A1KMT2A | |
| SCHEMBL14344914 | 0.77 | LIPE (0.35) | NOTUMLIPEKMT2A | |
| SCHEMBL17929144 | 0.77 | LIPE (0.35) | NOTUMLIPEKMT2A | |
| SCHEMBL23552252 | 0.77 | CYP1A2 (0.48) | CYP1A2TDP1SMN1; SMN2KDM4ENOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8513417-B2 | Method for synthesis of nitroxyl radical | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2013-08-20 | — | — | US | claimed |
| WO-2008099198-A2 | OSTEOGENIC COMPOUNDS | INION LIMITED (GB) | 2008-08-21 | — | — | WO | claimed |
| US-6436919-B1 | LOCAL ANESTHETICS THAT HAVE LONGER DURATION OF ACTION WHILE REDUCING UNDESIRED SIDE EFFECTS | THERAVANCE INC. | 2002-08-20 | — | — | US | claimed |
| EP-1216243-A1 | QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS | Advanced Medicine, Inc. (US) | 2002-06-26 | — | — | EP | claimed |
| WO-2001025234-A1 | QUINAZOLINONES AND ANALOGUES AND THEIR USE AS LOCAL ANESTHETICS | ADVANCED MEDICINE, INC. (US) | 2001-04-12 | — | — | WO | claimed |
| EP-0825183-B1 | Process for the preparation of 1-acetyl-4-piperidinones | BASF AG (DE) | 2000-02-16 | — | — | EP | claimed |
| US-5861513-A | Preparation of 1-acetyl-4-piperidones | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-19 | — | — | US | claimed |
| EP-0431943-B1 | Spiro(pyran)piperidine derivatives | MERCK & CO INC (US) | 1998-07-15 | — | — | EP | claimed |
| US-5665504-A | Simulated photographic-quality prints using a plasticizer to reduce curl | XEROX CORPORATION (US) | 1997-09-09 | — | — | US | claimed |
| EP-0552360-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-07-28 | — | — | EP | claimed |
| WO-1993003825-A1 | A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE | THE DOW CHEMICAL COMPANY (US) | 1993-03-04 | — | — | WO | claimed |
| US-5167941-A | Sulfur dioxide; cationic polyelectrolyte stabilizers | THE DOW CHEMICAL COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| EP-0219626-A2 | Film-forming compositions comprising polyglutarimide | International Business Machines Corporation (US) | 1987-04-29 | — | — | EP | claimed |
| EP-0201366-A1 | 5-H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridines, process for their preparation and their use as synthesis intermediates | SANOFI (FR) | 1986-11-12 | — | — | EP | claimed |
| EP-0197829-A1 | 5H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridine derivatives, process for their preparation and their antitunour activity | SANOFI (FR) | 1986-10-15 | — | — | EP | claimed |
| US-4036842-A | FRIEDEL CRAFTS CATALYST | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-07-19 | — | — | US | claimed |
| JP-10147571-A | — | — | None | — | — | JP | disclosed |
| US-20260116855-A1 | ORALLY ACTIVE MELANOCORTIN RECEPTOR-4 COMPOUNDS | PALATIN TECHNOLOGIES INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-3932650-A | TRANQUILIZERS | E. I. DU PONT DE NEMOURS & COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
| US-3931169-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116855-A1 | ORALLY ACTIVE MELANOCORTIN RECEPTOR-4 COMPOUNDS | MC1R, MC3R, MC5R | CYP1A2 2315/4885TDP1 4710/4885SMN1; SMN2 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.